Correlation Between Vincerx Pharma and Dogwood Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Dogwood Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Dogwood Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Dogwood Therapeutics,, you can compare the effects of market volatilities on Vincerx Pharma and Dogwood Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Dogwood Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Dogwood Therapeutics,.

Diversification Opportunities for Vincerx Pharma and Dogwood Therapeutics,

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vincerx and Dogwood is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Dogwood Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dogwood Therapeutics, and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Dogwood Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dogwood Therapeutics, has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Dogwood Therapeutics, go up and down completely randomly.

Pair Corralation between Vincerx Pharma and Dogwood Therapeutics,

Given the investment horizon of 90 days Vincerx Pharma is expected to generate 1.12 times more return on investment than Dogwood Therapeutics,. However, Vincerx Pharma is 1.12 times more volatile than Dogwood Therapeutics,. It trades about 0.02 of its potential returns per unit of risk. Dogwood Therapeutics, is currently generating about -0.03 per unit of risk. If you would invest  63.00  in Vincerx Pharma on September 12, 2024 and sell it today you would lose (41.50) from holding Vincerx Pharma or give up 65.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vincerx Pharma  vs.  Dogwood Therapeutics,

 Performance 
       Timeline  
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Dogwood Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dogwood Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Vincerx Pharma and Dogwood Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vincerx Pharma and Dogwood Therapeutics,

The main advantage of trading using opposite Vincerx Pharma and Dogwood Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Dogwood Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dogwood Therapeutics, will offset losses from the drop in Dogwood Therapeutics,'s long position.
The idea behind Vincerx Pharma and Dogwood Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation